Abstract: The present disclosure discloses a novel compound, 3,4-dihydroxyphenethyl 3-hydroxybutanoate, a method for preparing the same and use of the same, and in particular, a compound of formula I, use of the compound of formula I, optically pure isomers of the compound, a mixture of enantiomers in any ratio, or pharmaceutically acceptable salts thereof in preparing health food and drug for relieving brain fatigue, improving learning and memory abilities, and ameliorating mania mood related to brain fatigue.

Abstract: The present invention relates to the field of wound healing. More specifically, the present invention provides methods and compositions useful for improved wound healing via autologous stem cell mobilization. In one embodiment, a method for improving wound healing in a patient comprises administering to the patient a therapeutically effective amount of a stem cell mobilizer and a low dose of an immunosuppressive agent.

Abstract: The disclosure relates to a compound, 2-(3,4-dihydroxyphenyl)ethyl 3-hydroxybutanoate, for improving aortic endothelial cell function and use thereof. The compound is capable of inhibiting inflammatory response of the human aortic endothelial cells caused by a saturated fatty acid, and preventing an occurrence and progression of atherosclerosis. The compound is capable of reducing human aortic endothelial inflammation caused by a saturated fatty acid, for example, reducing the mRNA levels of interleukin-6 (IL-6), and is capable of effectively protecting the function of mitochondria in human aortic endothelium from being damaged by a saturated fatty acid, for example, increasing the expression of mitochondrial complex I.

Abstract: The disclosure relates to a compound, 2-(3,4-dihydroxyphenyl)ethyl 3-hydroxybutanoate, for improving aortic endothelial cell function and use thereof. The compound is capable of inhibiting inflammatory response of the human aortic endothelial cells caused by a saturated fatty acid, and preventing an occurrence and progression of atherosclerosis. The compound is capable of reducing human aortic endothelial inflammation caused by a saturated fatty acid, for example, reducing the mRNA levels of interleukin-6 (IL-6), and is capable of effectively protecting the function of mitochondria in human aortic endothelium from being damaged by a saturated fatty acid, for example, increasing the expression of mitochondrial complex I.

Abstract: Biodegradable implants sized and suitable for implantation in an ocular region or site and methods for treating ocular conditions. The implants provide an extended release of an active agent at a therapeutically effective amount for a period of time between 50 days and one year, or longer.

Abstract: A system and method includes soft-segment based rules optimization that can mitigate the overall false positives while maintaining 100% true positive detection. The soft clustering allows real-time re-assignment of an account to a dominate archetype behavior, as well as rule optimization based on a logical order with more relaxation on thresholds for the most inefficient rules is performed within each archetype. The rule optimization provides false positive reduction compared to a baseline rule system. The method can be used to reduce false positives for any rule-based detection system in which the same true positive detection is required.

Abstract: The present invention provides a tissue factor (TF) monoclonal antibody and a preparation method therefor. The monoclonal antibody provided by the present invention can specifically bind with a TF antigen, has high affinity and low immunogenicity, and has the activity of resisting tumors and the like.

Abstract: A backlight module includes a light guide panel, and first and second light sources. The light guide panel has a light-emitting surface and a bottom surface opposite to each other. Two adjacent sides of the bottom surface are respectively connected to a first light-incident surface, and a second light-incident surface. The first and second light sources are disposed adjacent to the first and second light-incident surfaces, respectively. Light-guiding patterns are arranged on the bottom surface or the light-emitting surface. Any adjacent two of the light-guiding patterns have a first pitch in a first direction and a second pitch in a second direction, respectively. The first pitch is decreased gradually from a position near the first light-incident surface toward a position far from the first light-incident surface. The second pitch is decreased gradually from a position near the second light-incident surface toward a position far from the second light-incident surface.

Abstract: Biodegradable implants sized and suitable for implantation in an ocular region or site and methods for treating ocular conditions. The implants provide an extended release of an active agent at a therapeutically effective amount for a period of time between 50 days and one year, or longer.

Abstract: The present invention provides a tissue factor (TF) monoclonal antibody and a preparation method therefor. The monoclonal antibody provided by the present invention can specifically bind with a TF antigen, has high affinity and low immunogenicity, and has the activity of resisting tumors and the like.

Abstract: A fence accessory includes at least two ornament bodies, each of the at least two ornament bodies including a first connecting part and a second connecting part at two opposing ends thereof. The first connecting part of one of the at least two ornament bodies and the second connecting part of an other one of the at least two ornament bodies are configured to be connected to a fence bar and clamped together as one unit. Moreover, each of the first connecting part and the second connecting part includes a hook and a slot at two opposing sides of the first connecting part and the second connecting part. The hook of the first connecting part of one ornament body is configured to connect to the slot of the second connecting part of an adjacent accessory body.

Abstract: An elbow for fence post includes an elbow body and a connector. The elbow body and the fence post are connected through the connector. An insertion hole is opened in the middle of the connector, and the lower end of the elbow body is configured to be inserted into the insertion hole under an interference fit. The outer ring of the connector has an annular groove which is configured to be embeds into the upper end of the post and connects with the external diameter under an interference fit.

Abstract: Biodegradable implants sized and suitable for implantation in an ocular region or site and methods for treating ocular conditions. The implants provide an extended release of an active agent at a therapeutically effective amount for a period of time between 50 days and one year, or longer.

Abstract: The present invention relates to a liquid (meth)acrylic syrup for impregnating a fibrous substrate. The present invention relates in particular to a viscous liquid syrup mainly containing methacrylic or acrylic components. The invention also relates to a process for manufacturing such a syrup. The invention also relates to a process for impregnating a fibrous substrate or long fibers with said viscous liquid syrup. The invention also relates to a fibrous substrate preimpregnated with said syrup, which is useful for manufacturing mechanical or structured parts or products. The present invention also relates to a manufacturing process for manufacturing mechanical or structured parts or articles and to three-dimensional mechanical or structured parts obtained by this process. The invention applies to the preparation of mechanical parts or structural elements made of fire-resistant thermoplastic composite material.

Abstract: A backlight module includes a light guide panel, and first and second light sources. The light guide panel has a light-emitting surface and a bottom surface opposite to each other. Two adjacent sides of the bottom surface are respectively connected to a first light-incident surface, and a second light-incident surface. The first and second light sources are disposed adjacent to the first and second light-incident surfaces, respectively. Light-guiding patterns are arranged on the bottom surface or the light-emitting surface. Any adjacent two of the light-guiding patterns have a first pitch in a first direction and a second pitch in a second direction, respectively. The first pitch is decreased gradually from a position near the first light-incident surface toward a position far from the first light-incident surface. The second pitch is decreased gradually from a position near the second light-incident surface toward a position far from the second light-incident surface.

Abstract: Provided are oxyntomodulin analogs. The peptide analogs have at least two cysteines. The two cysteines are separated by six amino acids such that they can be crosslinked using suitable crosslinking moieties. The crosslinked peptides have long half-lives and/or efficacy. For example, peptide analog compositions are used for inducing weight loss and/or reducing blood glucose levels.

Abstract: A degradable bearing pallet and a preparation method thereof. The pallet has an upper cover, a packing middle layer and a lower cover; a plurality of pallet support legs are disposed at the bottom of the lower cover; the lower cover is integrally molded with the plurality of pallet support legs; and the packing middle layer is filled in the lower cover and in the plurality of pallet support legs; the upper cover covers the packing middle layer and the lower cover. The middle part of the bottom of each of the pallet support legs is formed with a sunken groove; the pallet support legs in each of the rows are mutually connected through a connecting board; and each of the connecting boards is clamped in a corresponding one of the sunken grooves.

Abstract: The present invention provides a semi-crystalline polymer for a coating on an implantable device for controlling release of drug and methods of making and using the same.

Abstract: Provided are oxyntomodulin analogs. The peptide analogs have at least two cysteines. The two cysteines are separated by six amino acids such that they can be crosslinked using suitable crosslinking moieties. The crosslinked peptides have long half-lives and/or efficacy. For example, peptide analog compositions are used for inducing weight loss and/or reducing blood glucose levels.